Basic Information
Adocia is a clinical-stage biotechnology company specializing in the development of innovative formulations of therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. Its preclinical pipeline includes three products: BioChaperone LisPram, BioChaperone Glargine GLP-1, and BioChaperone Glucagon GLP1.
Adocia SA
Lyon,Auvergne-Lon-Alpes,France
51~100 people
January 01, 2005
emploi@adocia.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios